2016 ADA 76th Scientific Sessions

New Orleans, LA
June 10-14, 2016

Pharmacokinetic and Pharmacodynamic Profiles of Orally, Duodenally and Subcutaneously Delivered Insulin in Beagle Canines

2015 ADA 75th Scientific Sessions

Boston, MA
June 5-9, 2015

Preprandial Oral Insulin (ORMD-0801) Reduces Rapid-Acting Insulin Requirements and Fasting Glucose Levels in T1DM Patients

2014 ADA 74th Scientific Sessions

San Francisco, CA
June 13-17, 2014

Bedtime oral insulin lowers fasting blood glucose levels in T2DM patients

Improved oral insulin bioavailability when delivered in soft capsules

Comparative assessment of the glucose-lowering effect of multiple oral insulin (ORMD-0801) formulation variants in pigs

Yale Diabetes Symposium

Yale University West Campus, CT
May 14, 2014

Oral insulin capsules: Clinical Highlights

Diabetes Technology Society Meeting 2013

San Francisco, California
Oct 31-Nov2, 2013

A dose-response of blood glucose concentrations to orally delivered insulin in healthy subjects

ADA 73rd Annual Scientific Sessions

Chicago, Illinois
June 21-25, 2013

Dose response to oral insulin capsules in fasting, healthy subjects

Global Technology Community Diabetes Summit 2013

GTC Diabetes Summit 2013
April 29-30, 2013, Boston, MA

Oral insulin capsules towards management of Type 1 diabetes mellitus

European Atherosclerosis Society Congress

81st EAS Congress
June 2-5, 2013, Lyon, France

Decreased CRP levels in response to a six-week, once-daily oral insulin regimen

PLOS One

April 9, 2013

Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study

12th Annual Diabetes Technology Society Meeting

Bethesda, MD
Nov 8-10, 2012

Concomitant oral and subcutaneous insulin therapy toward stabilization of uncontrolled Type 1 Diabetes Mellitus

ADA 72nd Annual Scientific Sessions

Philidelphia, Pennsylvania
June 8-12, 2012

Concomitant oral insulin and exenatide therapies significantly curb postprandial glucose excursions in pigs

ISA 2012

Sydney, Australia
March 25-29, 2012

Decreased CRP Levels in response to a six week, once-daily oral insulin regimen

Diabetes Technology Meeting 2011

San Francisco, California
October 27-29, 2011

Evaluation of the Safety and Efficacy of Two Oral Insulin Formulations in Healthy Volunteers

ILAF Project

September 2011

A Model of Long Term Intestinal Access in the Pigs

Journal of Diabetes Science and Technology

November 2010
Volume 4, Issue 6

Novel Glucagon-Like Peptide-1 Analog Delivered Orally Reduces Postprandial Glucose Excursions in Porcine and Canine Models

Diabetes Technology Meeting 2010

Bethesda, Maryland
November 11-13, 2010

Extended exposure to an oral insulin formulation yields decreased insulin secretion in Type II diabetes subjects

ADA 70th Annual Scientific Sessions

Orlando, Florida
June 25-29, 2010

A Single-Blind, Two-Period Study to Assess the Safety and Pharmacodynamics of an Orally Delivered GLP-1 Analog (Exenatide) in Healthy Subjects

Oral insulin: Type 1 Diabetes (T1DM) Patient Response Upon Preprandial Administration

Diabetes, Obesity and Metabolism

March 2010
Volume 12

Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects

9th Annual Meeting of Diabetes Technology Society

San Francisco, California
5-7th November, 2009

A novel GLP-1 Analog delivered orally reduces postprandial glucose excursions in a porcine model

ADA 69th Annual Scientific Sessions

New Orleans, LA
June 5-9, 2009

Open-Label Study to Assess the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Oral Insulin Formulation in Subjects with Type 2 Diabetes (T2DM)

Journal of Diabetes Science and Technology

May 2009
Volume 3, Issue 3

Oral Insulin: The Rationale for This Approach and Current Developments

8th Annual Meeting of Diabetes Technology Society

Bethesda, Maryland
November 13-15, 2008

Enteral Administration of Exenatide-4; Proof of Concept Pharmacodynamic Study in Dogs

44th Annual Meeting of the European Association for the Study of Diabetes (EASD)

Rome, Italy
September 7-11, 2008

Open Label Study to Assess the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Five Oral Insulin Formulations in Healthy Subjects

ADA 68th Annual Scientific Sessions

San Francisco, California
June 6-10, 2008

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Oral Insulin in Healthy Subjects